Klarna KLAR Falls 792 Watching 1440 Support 20260515 Nationwide Board Challenge Could Reshape UK Mutual Governance Standards Raspberry Pi Boss Warns AI Fears Could Deter Tech Talent and Harm Economy EU Set to Revise Growth and Inflation Forecasts Amid Iran Conflict Stagflationary Shock Fanatics Secures FIFA Exclusive Collectibles License Expanding Dominance in Sports Memorabilia New Tax Season Rules May Benefit Online Sellers and EV Buyers HALO Stocks ETF Emerges as Investors Seek AIProof Investment Opportunities Feds Powell and Incoming Chair Warsh Face Historic Overlap Amid Policy Tensions Tulsi Gabbard Resigns as US National Intelligence Director Citing Husbands Illness UK Police Chiefs Call for Blocking Unsafe Social Media Platforms for Under16s PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed MeiraGTx Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline NMRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase ADM Q1 2026 Earnings EPS Beats Estimates by 66 as Agribusiness Shows Resilience BCS Q1 2026 Earnings EPS Beat by 1036 Despite Slight Stock Decline BlackRock Capital Allocation Term Trust BCAT Modestly Gains as Price Hovers Near MidRange Adicet Bio ACET Edges Higher Modest Gain Amid Key Support and Resistance Levels Unity Bancorp UNTY Edges Lower Amid Consolidation Near Support Levels Regency Centers REG Holds Steady Near Support Level as Trading Volume Remains Modest Toshifumi Suzuki 7Eleven Pioneer Who Redefined Convenience Retailing Dies at 93 BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains EMN Q1 2026 Earnings Earnings Beat on Lower Expectations Revenue Figures Not Disclosed Telus Q1 2026 Earnings EPS Beats Expectations Amid Cautious Growth Outlook PECO Q1 2026 Earnings Strong EPS Beat Driven by Robust Portfolio Performance MGRB Q1 2026 Earnings Earnings Beat Estimates Amidst Modest Stock Decline Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development